{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:01:43Z","timestamp":1792612903710,"version":"4.5.0"},"reference-count":106,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by systemic inflammation and the progressive damage of joints, significantly impacting patients\u2019 quality of life. Managing this condition requires a complex approach that integrates pharmacological and non-pharmacological therapies, alongside psychosocial support and patient education. Aim: This study aims to highlight the importance of an interdisciplinary approach in the treatment of rheumatoid arthritis, focusing on the role of pharmacological therapies, monitoring treatment response, and the involvement of a multidisciplinary team in the effective management of the disease. Methods: The analysis was based on a review of the specialised literature concerning the role of disease-modifying antirheumatic drugs (DMARDs, both conventional and biological), the use of inflammatory markers (CRP and ESR), advanced imaging techniques, and the contribution of various medical specialities to the holistic management of rheumatoid arthritis. A total of 595,900 records were identified, of which 53 studies were ultimately included in the detailed analysis. Relevant studies from fields such as rheumatology, nutrition, psychology, and physical therapy were included. Results: The findings underline that DMARDs, in combination with other pharmacological therapies, remain essential for slowing disease progression. Monitoring treatment response through inflammatory markers and imaging techniques allows for the adjustment of therapeutic strategies and the prevention of complications. An interdisciplinary approach, involving the rheumatologist, general practitioner, physiotherapist, nutritionist, and psychologist, provides significant benefits, such as reducing inflammation, improving joint function, and offering psychosocial support. Conclusions: The effective management of rheumatoid arthritis requires a personalised interdisciplinary approach. Integrating various specialities, along with patient education and psychosocial support, contributes to better disease management, the prevention of disabilities, and improved quality of life. This review is not registered.<\/jats:p>","DOI":"10.3390\/clinpract15060103","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:21:13Z","timestamp":1748427673000},"page":"103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR\/ACR 2025?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3996-6546","authenticated-orcid":false,"given":"Adriana Liliana","family":"Vlad","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDun\u0103rea de Jos\u201d University of Gala\u021bi, 800008 Gala\u021bi, Romania"},{"name":"\u201cSt. Apostle Andrei\u201d Clinical Emergency County Hospital, 800578 Gala\u021bi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-4674","authenticated-orcid":false,"given":"Corina","family":"Popazu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDun\u0103rea de Jos\u201d University of Gala\u021bi, 800008 Gala\u021bi, Romania"},{"name":"\u201cSt. Apostle Andrei\u201d Clinical Emergency County Hospital, 800578 Gala\u021bi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-4964","authenticated-orcid":false,"given":"Alina-Maria","family":"Lescai","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDun\u0103rea de Jos\u201d University of Gala\u021bi, 800008 Gala\u021bi, Romania"},{"name":"\u201cSt. Apostle Andrei\u201d Clinical Emergency County Hospital, 800578 Gala\u021bi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina Carina","family":"Voinescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDun\u0103rea de Jos\u201d University of Gala\u021bi, 800008 Gala\u021bi, Romania"},{"name":"\u201cSt. Apostle Andrei\u201d Clinical Emergency County Hospital, 800578 Gala\u021bi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia Anastasia \u0218tefania","family":"Balt\u0103","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, \u201cDun\u0103rea de Jos\u201d University of Gala\u021bi, 800008 Gala\u021bi, Romania"},{"name":"\u201cSt. Apostle Andrei\u201d Clinical Emergency County Hospital, 800578 Gala\u021bi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/jmp5040030","article-title":"Rheumatoid Arthritis: What Inflammation Do We Face?","volume":"5","author":"Poznyak","year":"2024","journal-title":"J. Mol. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lin, Y.-J., Anzaghe, M., and Sch\u00fclke, S. (2020). Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells, 9.","DOI":"10.3390\/cells9040880"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sundas, A., Contreras, I., Mujahid, O., Beneyto, A., and Vehi, J. (2024). The Effects of Environmental Factors on General Human Health: A Scoping Review. Healthcare, 12.","DOI":"10.3390\/healthcare12212123"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bo, M., Jasemi, S., Uras, G., Erre, G.L., Passiu, G., and Sechi, L.A. (2020). Role of Infections in the Pathogenesis of Rheumatoid Arthritis: Focus on Mycobacteria. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101459"},{"key":"ref_5","first-page":"591","article-title":"Global Epidemiology of Rheumatoid Arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3390\/cimb46050251","article-title":"Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts","volume":"46","author":"Coppola","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Carmona, L., Aurrecoechea, E., and Garc\u00eda de Y\u00e9benes, M.J. (2024). Tailoring Rheumatoid Arthritis Treatment through a Sex and Gender Lens. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010055"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102528","DOI":"10.1016\/j.autrev.2020.102528","article-title":"Rheumatoid Arthritis in the Elderly: Characteristics and Treatment Considerations","volume":"19","author":"Serhal","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ogbodo, J.O., Arazu, A.V., Iguh, T.C., Onwodi, N.J., and Ezike, T.C. (2022). Volatile organic compounds: A proinflammatory activator in autoimmune diseases. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.928379"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/17843286.2021.1992582","article-title":"Airborne pollutants as potential triggers of systemic autoimmune rheumatic diseases: A narrative review","volume":"77","author":"Celen","year":"2022","journal-title":"Acta Clin. Belg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid Arthritis: Extra-Articular Manifestations and Comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","article-title":"Difficult-to-Treat Rheumatoid Arthritis: Contributing Factors and Burden of Disease","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mueller, A.L., Payandeh, Z., Mohammadkhani, N., Mubarak, S.M., Zakeri, A., Alagheband Bahrami, A., and Shakibaei, M. (2021). Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells, 10.","DOI":"10.3390\/cells10113017"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/2772434418666230406083149","article-title":"Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments","volume":"19","author":"Khan","year":"2024","journal-title":"Recent Adv. Anti-Infect. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Oberemok, V.V., Andreeva, O., Laikova, K., Alieva, E., and Temirova, Z. (2023). Rheumatoid Arthritis Has Won the Battle but Not the War: How Many Joints Will We Save Tomorrow?. Medicina, 59.","DOI":"10.3390\/medicina59101853"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jang, S., Kwon, E.-J., and Lee, J.J. (2022). Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020905"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., and Zhang, L. (2021). B Cells in Rheumatoid Arthritis: Pathogenic Mechanisms and Treatment Prospects. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.750753"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0040-1708521","article-title":"HLA Polymorphisms and Food Allergy Predisposition","volume":"9","author":"Kostara","year":"2020","journal-title":"J. Pediatr. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rom\u00e3o, V.C., and Fonseca, J.E. (2021). Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.689698"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Arleevskaya, M., Takha, E., Petrov, S., Kazarian, G., Renaudineau, Y., Brooks, W., Larionova, R., Korovina, M., Valeeva, A., and Shuralev, E. (2022). Interplay of Environmental, Individual and Genetic Factors in Rheumatoid Arthritis Provocation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158140"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3830212","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"de Seny, D., Baiwir, D., Bianchi, E., Cobraiville, G., Deroyer, C., Poulet, C., Malaise, O., Paulissen, G., Kaiser, M.-J., and Hauzeur, J.-P. (2022). New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010434"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Nemcansky, J., Bradna, P., and Kolarcikova, V. (2024). Rheumatic Diseases. Ocular Manifestations of Systemic Diseases, Springer International Publishing.","DOI":"10.1007\/978-3-031-58592-0_6"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Radu, A.-F., and Bungau, S.G. (2021). Management of Rheumatoid Arthritis: An Overview. Cells, 10.","DOI":"10.3390\/cells10112857"},{"key":"ref_25","first-page":"102020","article-title":"Clinical Manifestations of Rheumatoid Arthritis, Including Comorbidities, Complications, and Long-Term Follow-Up","volume":"38","author":"Misra","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mpmed.2021.12.002","article-title":"Clinical Features of Rheumatoid Arthritis","volume":"50","author":"Colquhoun","year":"2022","journal-title":"Medicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.22270\/ajprd.v10i6.1200","article-title":"A Review on Rheumatoid Arthritis","volume":"10","author":"Sumathi","year":"2022","journal-title":"Asian J. Pharm. Res. Dev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kim, J.-W., and Suh, C.-H. (2020). Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9062008"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/rheumato4020007","article-title":"Subcutaneous Nodules as Manifestations of Systemic Disease","volume":"4","author":"Rothschild","year":"2024","journal-title":"Rheumato"},{"key":"ref_30","first-page":"e21914","article-title":"Rheumatoid Arthritis and Associated Lung Diseases: A Comprehensive Review","volume":"14","author":"Azam","year":"2022","journal-title":"Cureus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102796","DOI":"10.1016\/j.autrev.2021.102796","article-title":"Ocular Microvascular Damage in Autoimmune Rheumatic Diseases: The Pathophysiological Role of the Immune System","volume":"20","author":"Hysa","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pietschmann, P., Butylina, M., Kerschan-Schindl, K., and Sipos, W. (2022). Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158740"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Taylor, P.C., Atzeni, F., Balsa, A., Gossec, L., M\u00fcller-Ladner, U., and Pope, J. (2021). The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030509"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.ultrasmedbio.2020.04.015","article-title":"The Role of Musculoskeletal Ultrasound Imaging in Rheumatoid Arthritis","volume":"46","author":"Elangovan","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"R\u00f6nnelid, J., Turesson, C., and Kastbom, A. (2021). Autoantibodies in Rheumatoid Arthritis\u2014Laboratory and Clinical Perspectives. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.685312"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s42399-023-01613-x","article-title":"Clinical Significance of Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibodies in Rheumatoid Arthritis: Literature Review","volume":"5","author":"Rahali","year":"2023","journal-title":"SN Compr. Clin. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s10067-020-05049-9","article-title":"Profile of Common Inflammatory Markers in Treatment-Na\u00efve Patients with Systemic Rheumatic Diseases","volume":"39","author":"Kim","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_39","first-page":"1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation","volume":"4","author":"Moher","year":"2015","journal-title":"BMJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The Immunology of Rheumatoid Arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Viana, M.N., Leiguez, E., Guti\u00e9rrez, J.M., Rucavado, A., Markus, R.P., Mar\u00e7ola, M., and Fernandes, C.M. (2020). A Representative Metalloprotease Induces PGE2 Synthesis in Fibroblast-Like Synoviocytes via the NF-\u03baB\/COX-2 Pathway with Amplification by IL-1\u03b2 and the EP4 Receptor. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-59095-z"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1186\/s13063-020-04731-2","article-title":"TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid Arthritis (TREAT EARLIER): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Protocol","volume":"21","author":"Niemantsverdriet","year":"2020","journal-title":"Trials"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"El-Malah, A.A., Gineinah, M.M., Deb, P.K., Khayyat, A.N., Bansal, M., Venugopala, K.N., and Aljahdali, A.S. (2022). Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070827"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.31138\/mjr.230324.pca","article-title":"Prevalence, Causes and Outcomes of Acute Gastrointestinal Bleeding in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis","volume":"35","author":"Piplani","year":"2024","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20230040","DOI":"10.1515\/ohe-2023-0040","article-title":"Advancing Rheumatic Disease Treatment: A Journey Towards Better Lives","volume":"5","author":"Rehman","year":"2024","journal-title":"Open Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The Pathogenesis of Rheumatoid Arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid Arthritis: Advances in Treatment Strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_48","first-page":"e075658","article-title":"Therapeutic Advances in Rheumatoid Arthritis","volume":"384","author":"Brown","year":"2024","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41423-020-00526-2","article-title":"New Insights into the Cell- and Tissue-Specificity of Glucocorticoid Actions","volume":"18","author":"Quatrini","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2020.11.003","article-title":"Traditional and Modern Management Strategies for Rheumatoid Arthritis","volume":"512","author":"Akram","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2330458","DOI":"10.2214\/AJR.23.30458","article-title":"Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications","volume":"222","author":"Kamel","year":"2024","journal-title":"Am. J. Roentgenol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103437","DOI":"10.1016\/j.autrev.2023.103437","article-title":"To Treat or Not to Treat Rheumatoid Arthritis with Glucocorticoids? A Reheated Debate","volume":"23","author":"Cutolo","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/rheumatology\/keaa892","article-title":"Changes in the Pharmacological Management of Rheumatoid Arthritis over Two Decades","volume":"60","author":"Crossfield","year":"2021","journal-title":"Rheumatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-Term Glucocorticoid Treatment and High Relapse Rate Remain Unresolved Issues in the Real-Life Management of Polymyalgia Rheumatica: A Systematic Literature Review and Meta-Analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105730","DOI":"10.1016\/j.jbspin.2024.105730","article-title":"Recommendations of the French Society of Rheumatology for the Management in Current Practice of Patients with Polymyalgia Rheumatica","volume":"91","author":"Wendling","year":"2024","journal-title":"Jt. Bone Spine"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Mrid, R.B., Bouchmaa, N., Ainani, H., El Fatimy, R., Malka, G., and Mazini, L. (2022). Anti-Rheumatoid Drugs Advancements: New Insights into the Molecular Treatment of Rheumatoid Arthritis. Biomed. Pharmacother., 151.","DOI":"10.1016\/j.biopha.2022.113126"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lopez-Pedrera, C., Barbarroja, N., Pati\u00f1o-Trives, A.M., Luque-T\u00e9var, M., Collantes-Estevez, E., Escudero-Contreras, A., and P\u00e9rez-S\u00e1nchez, C. (2020). Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239067"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14656566.2023.2297798","article-title":"Advances in Non-Biological Drugs for the Treatment of Rheumatoid Arthritis","volume":"25","author":"Venetsanopoulou","year":"2024","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2174\/1381612828666220527141532","article-title":"Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab","volume":"28","author":"Nowak","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2147\/JIR.S282249","article-title":"Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y., and Liang, C. (2021). Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.686155"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Ko\u017ami\u0144ski, P., Halik, P.K., Chesori, R., and Gniazdowska, E. (2020). Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103483"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","article-title":"Efficacy of Pharmacological Treatment in Rheumatoid Arthritis: A Systematic Literature Research Informing the 2019 Update of the EULAR Recommendations for Management of Rheumatoid Arthritis","volume":"79","author":"Kerschbaumer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Promelle, V., Goeb, V., and Gueudry, J. (2021). Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102118"},{"key":"ref_65","first-page":"139","article-title":"Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis","volume":"13","author":"Mysler","year":"2021","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41584-023-00992-8","article-title":"Effect of DMARDs on the Immunogenicity of Vaccines","volume":"19","author":"Huckriede","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/1744666X.2019.1705785","article-title":"Infection Risk in Patients Undergoing Treatment for Inflammatory Arthritis: Non-Biologics versus Biologics","volume":"16","author":"Chiu","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10792-021-02058-8","article-title":"Natural and Iatrogenic Ocular Manifestations of Rheumatoid Arthritis: A Systematic Review","volume":"42","author":"Dammacco","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11926-020-00921-8","article-title":"Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment","volume":"22","author":"Drosos","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2019 Update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Barbarroja, N., Ruiz-Ponce, M., Cuesta-L\u00f3pez, L., Perez-Sanchez, C., Lopez-Pedrera, C., Arias-de La Rosa, I., and Collantes-Est\u00e9vez, E. (2022). Nonalcoholic Fatty Liver Disease in Inflammatory Arthritis: Relationship with Cardiovascular Risk. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.997270"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of Synthetic and Biological DMARDs: A Systematic Literature Review Informing the 2019 Update of the EULAR Recommendations for the Management of Rheumatoid Arthritis","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14712598.2024.2307340","article-title":"The Latest Advances in the Use of Biological DMARDs to Treat Still\u2019s Disease","volume":"24","author":"Ruscitti","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3899\/jrheum.190535","article-title":"Reasons for Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Cessation and Persistence of Second-Line Treatment in a Rheumatoid Arthritis Dataset","volume":"47","author":"Youssef","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100725","DOI":"10.1016\/j.nmni.2020.100725","article-title":"Evaluation of Platelet Count, Erythrocyte Sedimentation Rate and C-Reactive Protein Levels in Paediatric Patients with Inflammatory and Infectious Disease","volume":"37","author":"Sherkatolabbasieh","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00325481.2022.2052626","article-title":"Biomarkers for the Diagnosis and Treatment of Rheumatoid Arthritis\u2014A Systematic Review","volume":"135","author":"Abdelhafiz","year":"2023","journal-title":"Postgrad. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","article-title":"C-Reactive Protein and Implications in Rheumatoid Arthritis and Associated Comorbidities","volume":"51","author":"Pope","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Targo\u0144ska-St\u0119pniak, B., Zwolak, R., Piotrowski, M., Grzechnik, K., and Majdan, M. (2020). The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092760"},{"key":"ref_80","first-page":"1073","article-title":"High Quantitative CRP and Low Albumin as Markers of Disease Activity in Patients with Rheumatoid Arthritis","volume":"4","author":"Ullah","year":"2024","journal-title":"J. Health Rehabil. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the Joints: The Extra-Articular Manifestations in Rheumatoid Arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"100079","DOI":"10.1016\/j.neuri.2022.100079","article-title":"A Review of Arthritis Diagnosis Techniques in Artificial Intelligence Era: Current Trends and Research Challenges","volume":"2","author":"Imtiaz","year":"2022","journal-title":"Neurosci. Inform."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.5114\/pjr.2022.113390","article-title":"Magnetic Resonance Imaging of Rheumatological Diseases","volume":"87","author":"Weaver","year":"2022","journal-title":"Pol. J. Radiol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Gukova, X., Hazlewood, G.S., Arbillaga, H., MacMullan, P., Zimmermann, G.L., Barnabe, C., and Barber, C.E. (2022). Development of an Interdisciplinary Early Rheumatoid Arthritis Care Pathway. BMC Rheumatol., 6.","DOI":"10.1186\/s41927-022-00267-x"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/annrheumdis-2019-215458","article-title":"2018 Update of the EULAR Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis","volume":"79","author":"Bech","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_86","first-page":"e38705","article-title":"Navigating Pain in Rheumatology: A Physiotherapy-Centric Review on Non-Pharmacological Pain Management Strategies","volume":"15","author":"Mohapatra","year":"2023","journal-title":"Cureus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"103333","DOI":"10.1016\/j.autrev.2023.103333","article-title":"Nutrition and Its Role in Prevention and Management of Rheumatoid Arthritis","volume":"22","author":"Nikiphorou","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Nagy, Z., Szigedi, E., Tak\u00e1cs, S., and Cs\u00e1sz\u00e1r-Nagy, N. (2023). The Effectiveness of Psychological Interventions for Rheumatoid Arthritis (RA): A Systematic Review and Meta-Analysis. Life, 13.","DOI":"10.3390\/life13030849"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/JMDH.S405904","article-title":"Emotional Distress in Patients Following Polytrauma","volume":"16","author":"Anghele","year":"2023","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00296-023-05380-9","article-title":"The Benefits of Physical Therapy in Juvenile Idiopathic Arthritis","volume":"43","author":"Felt","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/acr2.11650","article-title":"The Impact of Occupational Therapy on the Self-Management of Rheumatoid Arthritis: A Mixed Methods Systematic Review","volume":"6","author":"Gavin","year":"2024","journal-title":"ACR Open Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hex.12982","article-title":"Patients and Relatives Coping with Inflammatory Arthritis: Care Teamwork","volume":"23","author":"Brignon","year":"2020","journal-title":"Health Expect."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00296-021-04907-2","article-title":"Tele-Health Interventions to Support Self-Management in Adults with Rheumatoid Arthritis: A Systematic Review","volume":"41","author":"MacIver","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_94","first-page":"183","article-title":"Systemic Immune-Inflammation Index in Evaluation of Inflammation in Rheumatoid Arthritis Patients","volume":"39","author":"Dervisevic","year":"2024","journal-title":"Medeni. Med. J."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Cierpiak, K., Wityk, P., Kosowska, M., Soko\u0142owski, P., Tala\u015bka, T., Gierowski, J., and Szczerska, M. (2024). C-Reactive Protein (CRP) Evaluation in Human Urine Using Optical Sensor Supported by Machine Learning. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-67821-0"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00520-024-08700-2","article-title":"Associations of Three Differential White Blood Cell Counts, Platelet Counts, and Their Derived Inflammatory Indices with Cancer-Related Fatigue in Patients with Breast Cancer Undergoing Chemotherapy","volume":"32","author":"Li","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101115","DOI":"10.1016\/j.currproblcancer.2024.101115","article-title":"Prognostic Risk Stratification Using C-Reactive Protein, Albumin, and Associated Inflammatory Biomarkers in Patients with Advanced Cancer in Palliative Care","volume":"51","author":"Wiegert","year":"2024","journal-title":"Curr. Probl. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.rdc.2024.07.007","article-title":"New Developments in Imaging in Crystalline Arthritis","volume":"50","author":"Thiele","year":"2024","journal-title":"Rheum. Dis. Clin."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"100051","DOI":"10.1016\/j.ntm.2024.100051","article-title":"Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment","volume":"3","author":"Shukla","year":"2024","journal-title":"Nano TransMed"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e000536","DOI":"10.1136\/rmdopen-2017-000536","article-title":"Glucocorticoids in Rheumatoid Arthritis: Current Status and Future Studies","volume":"6","author":"Hua","year":"2020","journal-title":"RMD Open"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2352019","DOI":"10.1080\/07853890.2024.2352019","article-title":"Use of Corticosteroids in Non-Infectious Uveitis\u2014Expert Consensus in Taiwan","volume":"56","author":"Chang","year":"2024","journal-title":"Ann. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Pavlov-Dolijanovic, S., Bogojevic, M., Nozica-Radulovic, T., Radunovic, G., and Mujovic, N. (2023). Elderly-Onset Rheumatoid Arthritis: Characteristics and Treatment Options. Medicina, 59.","DOI":"10.3390\/medicina59101878"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Singh, S., Tiwary, N., Sharma, N., Behl, T., Antil, A., Anwer, M.K., Ramniwas, S., Sachdeva, M., Elossaily, G.M., and Gulati, M. (2024). Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020248"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Inchingolo, F., Inchingolo, A.M., Fatone, M.C., Avantario, P., Del Vecchio, G., Pezzolla, C., Mancini, A., Galante, E., Palermo, A., and Inchingolo, A.D. (2024). Management of Rheumatoid Arthritis in Primary Care: A Scoping Review. Int. J. Environ. Res. Public Health, 21.","DOI":"10.3390\/ijerph21060662"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Andronache, I.-T., \u0218u\u021ba, V.-C., \u0218u\u021ba, M., Ciocodei, S.-L., Vl\u0103d\u0103reanu, L., Nicoar\u0103, A.D., and Arghir, O.C. (2023). Better Safe than Sorry: Rheumatoid Arthritis, Interstitial Lung Disease, and Medication\u2014A Narrative Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061755"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Bedekovi\u0107, D., Bo\u0161njak, I., \u0160ari\u0107, S., Kirner, D., and Novak, S. (2023). Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review. Medicina, 59.","DOI":"10.20944\/preprints202308.0435.v1"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/6\/103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:42:21Z","timestamp":1760031741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/15\/6\/103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":106,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["clinpract15060103"],"URL":"https:\/\/doi.org\/10.3390\/clinpract15060103","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}